Research Site

Yongkang District 71004

1 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Renal Disease, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus, CKD and Albuminuria

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria — Completed
• A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD — Completed
• Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications — Completed